A detailed history of Baltimore Washington Financial Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Baltimore Washington Financial Advisors, Inc. holds 3,115 shares of MRK stock, worth $308,945. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,115
Previous 3,115 -0.0%
Holding current value
$308,945
Previous $385,000 8.31%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$123.8 - $132.96 $29,464 - $31,644
238 Added 8.27%
3,115 $385,000
Q1 2024

May 08, 2024

SELL
$113.24 - $131.95 $22,874 - $26,653
-202 Reduced 6.56%
2,877 $379,000
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $30,054 - $32,706
-300 Reduced 8.88%
3,079 $335,000
Q3 2023

Nov 08, 2023

BUY
$102.95 - $114.33 $26,355 - $29,268
256 Added 8.2%
3,379 $347,000
Q2 2023

Aug 09, 2023

SELL
$108.61 - $118.38 $5,321 - $5,800
-49 Reduced 1.54%
3,123 $360,000
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $5,044 - $5,628
-49 Reduced 1.52%
3,172 $337,000
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $699 - $896
-8 Reduced 0.25%
3,221 $357,000
Q3 2022

Oct 31, 2022

BUY
$84.53 - $94.96 $18,343 - $20,606
217 Added 7.2%
3,229 $278,000
Q2 2022

Aug 05, 2022

BUY
$83.49 - $94.64 $9,350 - $10,599
112 Added 3.86%
3,012 $274,000
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $11,026 - $12,360
-150 Reduced 4.92%
2,900 $223,000
Q4 2021

Apr 08, 2022

BUY
$72.28 - $90.54 $207,154 - $259,487
2,866 Added 1557.61%
3,050 $233,000
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $196,312 - $245,906
-2,716 Reduced 93.66%
184 $233,000
Q1 2021

May 06, 2021

SELL
$68.86 - $81.11 $23,068 - $27,171
-335 Reduced 10.36%
2,900 $223,000
Q4 2020

Feb 01, 2021

BUY
$71.77 - $79.65 $4,306 - $4,779
60 Added 1.89%
3,235 $264,000
Q3 2020

Nov 03, 2020

BUY
$73.18 - $82.95 $16,904 - $19,161
231 Added 7.85%
3,175 $263,000
Q2 2020

Aug 10, 2020

BUY
$70.42 - $80.13 $1,690 - $1,923
24 Added 0.82%
2,944 $227,000
Q4 2019

Feb 04, 2020

SELL
$77.58 - $87.54 $3,103 - $3,501
-40 Reduced 1.35%
2,920 $265,000
Q3 2019

Oct 16, 2019

SELL
$76.08 - $82.93 $7,608 - $8,293
-100 Reduced 3.27%
2,960 $249,000
Q2 2019

Jul 25, 2019

SELL
$69.84 - $81.59 $10,056 - $11,748
-144 Reduced 4.49%
3,060 $257,000
Q1 2019

Apr 18, 2019

BUY
$69.58 - $79.36 $10,297 - $11,745
148 Added 4.84%
3,204 $266,000
Q4 2018

Jan 29, 2019

SELL
$65.24 - $75.71 $6,523 - $7,570
-100 Reduced 3.17%
3,056 $233,000
Q3 2018

Nov 01, 2018

SELL
$57.69 - $67.84 $60,632 - $71,299
-1,051 Reduced 24.98%
3,156 $223,000
Q2 2018

Jul 30, 2018

BUY
$50.83 - $59.72 $2,897 - $3,404
57 Added 1.37%
4,207 $255,000
Q1 2018

Apr 16, 2018

SELL
$50.96 - $59.23 $5.28 Million - $6.14 Million
-103,612 Reduced 96.15%
4,150 $226,000
Q4 2017

Jan 16, 2018

SELL
$51.62 - $61.64 $53,891 - $64,352
-1,044 Reduced 0.96%
107,762 $6.06 Million
Q3 2017

Oct 18, 2017

BUY
$58.67 - $63.13 $6.38 Million - $6.87 Million
108,806
108,806 $6.97 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Baltimore Washington Financial Advisors, Inc. Portfolio

Follow Baltimore Washington Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baltimore Washington Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baltimore Washington Financial Advisors, Inc. with notifications on news.